Research Design Service: West Midlands
« back

NIHR: UK-wide antiviral clinical trial platform in non-hospitalised patients

  Tuesday, 17 Aug 2021 | Funding Deadline

NIHR are seeking to fund a research consortium to deliver a complex community-based clinical trial platform for antiviral candidates for COVID-19 that could augment the current vaccine and therapeutic programmes.

The Antivirals Taskforce (ATF) has been established by the Department of Health and Social Care (DHSC) to identify effective antiviral treatments for COVID-19 to augment the current vaccine and therapeutic programmes. The ATF is seeking to make available oral (tablet or capsule) drugs that could be taken in non-hospitalised patients. The primary focus will be early treatment of confirmed (PCR positive) SARS-CoV2 infections in high-risk individuals to prevent hospitalisation, reduce symptoms, and speed up recovery.

The ATF is seeking to commission a research consortium that will be able to deliver a complex community-based clinical trial platform for antiviral candidates, focused primarily on major public health outcomes, notably reductions in hospitalisation and mortality.

 

Deadline for proposals: 17 August 2021

Find out more here